Supply Chain | July 12, 2025
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
To streamline complex medical writing workflows with GenAI
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Commercial production is expected to begin soon
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
The acquisition of Pivya is an important step in Alembic’s ability to provide branded pharmaceutical product to the US Healthcare market
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
Subscribe To Our Newsletter & Stay Updated
